These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 27343306)

  • 1. Clinicopathologic characteristics and treatment features of women with the incidental diagnosis of endometrial adenocarcinoma during infertility follow-up in Ankara, Turkey.
    Gungor T; Cetinkaya N; Yalcin H; Zergeroglu S; Erkaya S
    Taiwan J Obstet Gynecol; 2016 Jun; 55(3):309-13. PubMed ID: 27343306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: Safety and Efficacy.
    De Marzi P; Bergamini A; Luchini S; Petrone M; Taccagni GL; Mangili G; Colombo G; Candiani M
    J Minim Invasive Gynecol; 2015; 22(7):1178-82. PubMed ID: 26092080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levonorgestrel-releasing intrauterine device plus metformin, or megestrol acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial carcinoma: a prospective, randomized, blind-endpoint design trial protocol.
    Zhao X; Niu J; Shi C; Liu Z
    Reprod Health; 2022 Nov; 19(1):206. PubMed ID: 36333773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fertility-Sparing Treatment of Early Endometrial Cancer and Complex Atypical Hyperplasia in Young Women of Childbearing Potential.
    Pronin SM; Novikova OV; Andreeva JY; Novikova EG
    Int J Gynecol Cancer; 2015 Jul; 25(6):1010-4. PubMed ID: 25950126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occult myometrial recurrence after progesterone therapy to preserve fertility in a young patient with endometrial cancer.
    Hurst SA; Hartzfeld KM; Del Priore G
    Fertil Steril; 2008 Mar; 89(3):724.e1-3. PubMed ID: 17570366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of high-dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium.
    Park H; Seok JM; Yoon BS; Seong SJ; Kim JY; Shim JY; Park CT
    Arch Gynecol Obstet; 2012 Feb; 285(2):473-8. PubMed ID: 21706284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadotropin releasing hormone agonist and levonorgestrel-intrauterine device followed by in vitro fertilization program as management strategy for an infertile endometrial cancer patient: a case report.
    Nucera G; Mandato VD; Gelli MC; Palomba S; La Sala GB
    Gynecol Endocrinol; 2013 Mar; 29(3):219-21. PubMed ID: 23153053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fertility-sparing management of low-grade endometrial stromal sarcoma: analysis of an institutional series and review of the literature.
    Laurelli G; Falcone F; Scaffa C; Messalli EM; Del Giudice M; Losito S; Greggi S
    Eur J Obstet Gynecol Reprod Biol; 2015 Dec; 195():61-66. PubMed ID: 26476800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined Oral Medroxyprogesterone/Levonorgestrel-Intrauterine System Treatment for Women With Grade 2 Stage IA Endometrial Cancer.
    Hwang JY; Kim DH; Bae HS; Kim ML; Jung YW; Yun BS; Seong SJ; Shin E; Kim MK
    Int J Gynecol Cancer; 2017 May; 27(4):738-742. PubMed ID: 28346240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fertility-Preserving Treatment in Young Women With Grade 1 Presumed Stage IA Endometrial Adenocarcinoma: A Meta-Analysis.
    Fan Z; Li H; Hu R; Liu Y; Liu X; Gu L
    Int J Gynecol Cancer; 2018 Feb; 28(2):385-393. PubMed ID: 29266019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy outcomes after fertility-sparing management in young women with early endometrial cancer.
    Park JY; Seong SJ; Kim TJ; Kim JW; Kim SM; Bae DS; Nam JH
    Obstet Gynecol; 2013 Jan; 121(1):136-42. PubMed ID: 23262938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fertility-sparing treatment of endometrial cancer precursors among young women: a reproductive point of view.
    Ricciardi E; Maniglio P; Frega A; Marci R; Caserta D; Moscarini M
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1934-7. PubMed ID: 23242719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of fertility-sparing treatment with megestrol acetate following hysteroscopic curettage for well-differentiated endometrioid carcinoma and atypical hyperplasia in young women.
    Shan BE; Ren YL; Sun JM; Tu XY; Jiang ZX; Ju XZ; Zang RY; Wang HY
    Arch Gynecol Obstet; 2013 Nov; 288(5):1115-23. PubMed ID: 23644919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Live births and maintenance with levonorgestrel IUD improve disease-free survival after fertility-sparing treatment of atypical hyperplasia and early endometrial cancer.
    Novikova OV; Nosov VB; Panov VA; Novikova EG; Krasnopolskaya KV; Andreeva YY; Shevchuk AS
    Gynecol Oncol; 2021 Apr; 161(1):152-159. PubMed ID: 33461741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial adenocarcinoma in young-aged women: a Turkish population study.
    Gungor T; Cetinkaya N; Ozdal B; Yalcin H; Erkaya S; Yakut HI
    Eur J Gynaecol Oncol; 2015; 36(6):667-71. PubMed ID: 26775348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy outcomes using assisted reproductive technology after fertility-preserving therapy in patients with endometrial adenocarcinoma or atypical complex hyperplasia.
    Han AR; Kwon YS; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
    Int J Gynecol Cancer; 2009 Jan; 19(1):147-51. PubMed ID: 19258957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pregnant rate and pregnancy-relating factors of patients with early endometrial carcinoma and severe atypical hyperplasia of endometrium after fertility-preserving treatment by progestin].
    Cao DY; Yu M; Yang JX; Shen K; Huang HF; Cheng NH; Sun ZY; Deng CY; Yu Q; He FF
    Zhonghua Fu Chan Ke Za Zhi; 2013 Jul; 48(7):519-22. PubMed ID: 24284224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of dilatation & curettage and endometrial aspiration biopsy accuracy in patients treated with high-dose oral progestin plus levonorgestrel intrauterine system for early-stage endometrial cancer.
    Kim MK; Seong SJ; Song T; Kim ML; Yoon BS; Jun HS; Lee GH; Lee YH
    Gynecol Oncol; 2013 Sep; 130(3):470-3. PubMed ID: 23822890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hysteroscopic Endometrial Focal Resection followed by Levonorgestrel Intrauterine Device Insertion as a Fertility-Sparing Treatment of Atypical Endometrial Hyperplasia and Early Endometrial Cancer: A Retrospective Study.
    Giampaolino P; Di Spiezio Sardo A; Mollo A; Raffone A; Travaglino A; Boccellino A; Zizolfi B; Insabato L; Zullo F; De Placido G; Bifulco G
    J Minim Invasive Gynecol; 2019; 26(4):648-656. PubMed ID: 30017893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged conservative treatment of endometrial cancer patients: more than 1 pregnancy can be achieved.
    Perri T; Korach J; Gotlieb WH; Beiner M; Meirow D; Friedman E; Ferenczy A; Ben-Baruch G
    Int J Gynecol Cancer; 2011 Jan; 21(1):72-8. PubMed ID: 21178572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.